S

Shire Pharmaceuticals

288 employees

Shire biotechnology company that focuses on serving people with rare diseases.

Investor insights

Sectors invested in

Biotechnology6
Therapeutics4
Pharmaceutical3
Biopharma2
Health Care2
Regenerative medicine2
Antibodies2
Biotech2
liver based genetic diseases2
Clinical stage2
NASH2
ACLF2
Acquired liver diseases2
Acute liver disease2
Liver diseases2
Chronic liver disease2
Cell therapy2
Fatty liver2
MPS 21
Life Science1

Funding rounds participated in

$15M sweet spot round size

Most of their 12 investments are in rounds between $7M and $25M

Basic info

Sectors

Biotechnology
Health Care
Therapeutics
Genetics
Wellness
Biopharma

Date founded

1986

Investments made

R

Rani Therapeutics raised $53M on February 7, 2018

Investors: VI Ventures, GV, PingAn Ventures and Shire Pharmaceuticals

P

Promethera Biosciences raised $31M on November 25, 2014

Investors: SFPI-FPIM and Shire Pharmaceuticals

N

Naurex Inc. raised $25M on May 6, 2014

Investors: Shire Pharmaceuticals

U

Undisclosed raised $17M on March 25, 2014

Investors: Shire Pharmaceuticals

U

Undisclosed raised $6.4M on May 6, 2013

Investors: Shire Pharmaceuticals

A

ArmaGen Pharmaceuticals raised $17M on November 29, 2012

Investors: Takeda UK Limited and Shire Pharmaceuticals

U

Undisclosed raised $3M on October 15, 2012

Investors: Morgenthaler, Forbion, Easton Capital Investment Group, HealthCare Ventures LLC, Polaris Partners and Shire Pharmaceuticals

P

Promethera Biosciences raised $31M on March 28, 2012

Investors: Shire Pharmaceuticals

E

Enterome raised $9.9M on March 23, 2012

Investors: Lundbeckfonden / Lundbeck Foundation, Seventure Partners, Omnes and Shire Pharmaceuticals

U

Undisclosed raised $9M on March 8, 2012

Investors: Shire Pharmaceuticals

FAQ